✦ LIBER ✦

Combination of sorafenib and doxorubicin in patients with advanced hepatocellular carcinoma: Results from a phase I extension trial

✍ Scribed by H. Richly; B. Schultheis; I.A. Adamietz; P. Kupsch; M. Grubert; R.A. Hilger; M. Ludwig; E. Brendel; O. Christensen; D. Strumberg

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase I study investigating everolimus c

✍ Finn, Richard S.; Poon, Ronnie T.P.; Yau, Thomas; Klümpen, Heinz-Josef; Chen, Li 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 577 KB

Phase 1 trial of S-1 in combination with

✍ Su Jin Lee, Jeeyun Lee, Se Hoon Park, Joon Oh Park, Young Suk Park, Won Ki Kang, 📂 Article 📅 2011 🏛 Springer US 🌐 English ⚖ 156 KB

A phase I/II trial of capecitabine combi

✍ Ogasawara, Sadahisa; Chiba, Tetsuhiro; Ooka, Yoshihiko; Kanogawa, Naoya; Motoyam 📂 Article 📅 2014 🏛 Springer US 🌐 English ⚖ 248 KB

Phase II trial of sorafenib in combinati

✍ Iacopo Petrini; Monica Lencioni; Miriam Ricasoli; Mauro Iannopollo; Cinzia Orlan 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 261 KB

Phase 2 Study of Combined Sorafenib and

✍ Chen, Shang-Wen; Lin, Li-Ching; Kuo, Yu-Cheng; Liang, Ji-An; Kuo, Chia-Chun; Chi 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 489 KB

Pharmacokinetic results of a phase I tri

✍ Erich Brendel; Matthias Ludwig; Chetan Lathia; Caroline Robert; Stanislas Ropert 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 367 KB